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Introduction:  Promising  treatments  for  tympanic  membrane  perforation  closure  have  been
studied.  Therapies  derived  from  tissue  engineering  probably  eliminate  the  need  for  conven-
tional surgery.  Bacterial  cellulose  is  presented  as  an  alternative  that  is  safe,  biocompatible,
and has  low  toxicity.
Objectives:  To  investigate  the  effect  on  healing  of  direct  application  of  a  bacterial  cellulose
graft on  the  tympanic  membrane  compared  to  the  conventional  approach  with  autologous
fascia.
Methods:  Randomized  controlled  trial.  Forty  patients  with  tympanic  membrane  perforations
secondary to  chronic  otitis  media  were  included,  and  were  randomly  assigned  to  an  experi-
mental  group  (20),  treated  with  a  bacterial  cellulose  graft  (BC)  and  control  group  (20),  treated
with autologous  temporal  fascia  (fascia).  We  evaluated  the  surgical  time,  hospital  stay,  time  of
epithelialization  and  the  rate  of  tympanic  perforation  closure.  Hospital  costs  were  compared.
The statistical  signiﬁcance  level  accepted  was  established  at  p  <  0.05.
Results:  The  closure  of  perforations  was  similar  in  both  groups.  The  average  operation  time  in
the fascia  group  was  76.50  min  versus  14.06  min  bacterial  cellulose  in  the  group  (p  =  0.0001).
The hospital  cost  by  the  Brazilian  public  health  system  was  R$  600.00  for  the  bacterial  cellulose
group, and  R$  7778.00  for  the  fascia  group  (p  =  0.0001).
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Conclusion:  Bacterial  cellulose  grafts  promoted  the  closure  of  the  tympanic  membrane  perfora-
tions, and  were  demonstrated  to  be  innovative,  effective,  safe,  minimally  invasive,  efﬁcacious
and to  have  a  very  low  cost.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published







Tratamento  do  tímpano  perfurado  com  enxerto  de  celulose  bacteriana:  ensaio  clínico
controlado  e  randomizado
Resumo
Introduc¸ão:  Tratamentos  promissores  para  o  fechamento  da  perfurac¸ão  da  membrana  tim-
pânica vêm  sendo  estudados.  Terapias  provenientes  de  engenharia  de  tecidos  provavelmente
eliminarão  a  necessidade  de  uma  intervenc¸ão  cirúrgica  convencional.  A  celulose  bacteriana
apresenta-se  como  uma  alternativa  por  ser  segura,  de  baixa  toxicidade,  biocompatível.
Objetivos:  Investigar  o  efeito  da  aplicac¸ão  direta  do  enxerto  da  celulose  bacteriana  na
cicatrizac¸ão de  perfurac¸ões  da  membrana  timpânica,  comparado  ao  procedimento  convencional
com fáscia  autóloga.
Método:  Incluíram-se  40  pacientes  com  perfurac¸ão  da  membrana  timpânica  por  otite  média
crônica simples.  Randomizados  de  1  a  40,  onde  os  ímpares  (20)  foram  tratados  com  enxerto  de
celulose bacteriana  (CB),  e  os  pares  (20),  com  enxerto  de  fáscia  temporal  autóloga  (fáscia).
Estudo clínico  controlado  e  randomizado.  O  tempo  cirúrgico  e  de  hospitalizac¸ão  foram  o  tempo
de epitelizac¸ão  e  custos  hospitalares.
Resultados:  O  fechamento  das  perfurac¸ões  foi  semelhante  nos  dois  grupos.  O  tempo  médio
da cirurgia  no  grupo  fáscia  foi  de  76,50  minutos  e  de  14,06  minutos  no  grupo  com  celulose
bacteriana  (p  =  0,0001).  O  custo  hospitalar  pela  tabela  do  SUS  foi  de  R$  600,00  para  o  grupo  CB
e R$  7.778,00  para  o  grupo  fáscia  (p  =  0,0001).
Conclusão:  A  celulose  bacteriana  promoveu  o  fechamento  da  perfurac¸ão  do  tímpano,
mostrando-se  inovador,  seguro,  eﬁcaz,  efetivo,  minimamente  invasivo  e  de  baixo  custo.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publi-









































romising  treatments  for  closure  of  tympanic  mem-
rane  perforation  (TMP)  have  been  studied,  in  search  of
utpatient,  minimally  invasive  procedures  that  are  effec-
ive,  safe,  affordable  and  technically  feasible.1--5 Among
ome  innovative  alternatives,  the  use  of  gelfoamTM and
telocollagenTM stand  out,  in  association  with  ﬁbroblast
rowth  factor  (-FGF),1--4 autologous  serum,  and  chitin
embranes.5
The  establishment  of  a  therapy  developed  from  tissue
ngineering  for  treatment  of  TMP  will  probably  eliminate
he  need  for  conventional  surgery.  However,  it  is  critical
o  understand  the  factors  that  contribute  to  the  success  or
ailure  of  TMP  treatment.4
An  alternative  material  is  cellulosic  polysaccharide,
btained  by  bacterial  synthesis.  In  previous  studies,  cel-
ulosic  polysaccharide  proved  to  be  a  safe,  low-toxicity,6
iocompatible7 product,  with  the  ability  to  encourage  cellu-
ar  growth  and  differentiation  --  a  feature  that  is  promising
or  tissue  engineering.8 Preclinical  and  clinical  studies  have
emonstrated  that  this  biomaterial  was  effective  func-
ioning  as  a  mechanical  barrier  and  as  an  adjunct  in  the
reatment  of  ulcerative  lesions9 and  surgical  wounds.10
The  objective  of  this  study  was  to  investigate  the  effect
f  direct  application  of  a  bacterial  cellulose  (BC)  graft  on
B
b
Uhe  healing  of  tympanic  membrane  perforations,  compared
ith  a  conventional  procedure  with  autologous  fascia.
ethod
orty  patients  with  tympanic  membrane  perforations  caused
y  otitis  media  were  enrolled  in  a  randomized  controlled
linical  study  of  spontaneous  demand  at  Otolaryngology
ervice  in  a  teaching  hospital  in  Pernambuco  state,  Brazil,
rom  2013  to  2014.  Patients  with  marginal,  damp  or
holesteatomatous  perforations  were  excluded.  Patients
ere  randomly  allocated  to  two  groups:  20  in  an  experi-
ental  group,  who  were  treated  with  bacterial  cellulose
embrane  graft,  and  20  controls  treated  conventionally
ith  autologous  fascia  graft.
This  study  was  approved  by  the  Ethics  Committee  on
esearch,  Health  Sciences  Center,  Universidade  Federal  de
ernambuco,  under  CAAE  21109913.7.0000.5208,  Opinion
EP/CONEP  No.  527.461  of  December  18,  2013.
acterial  cellulose  graft
acterial  cellulose  grafts  were  manufactured  and  supplied
y  PolisaTM, a Sugar  Cane  Experimental  Station,  Carpina  City,




























brane  in  the  group  treated  with  BC  graft  was  lower  (50%)
than  that  for  the  group  with  autologous  fascia  graft.  The
effectiveness  was  50%,  a  result  similar  for  both  materialsTreatment  of  tympanic  membrane  perforation  using  bacteri
Technical  procedures
Patients  included  in  control  group  underwent  miringoplasty
with  temporal  fascia  graft,  performed  under  general  anes-
thesia,  according  to  standard  operating  procedures  for  this
surgery.  The  graft  of  fascia  was  applied  medial  to  the
tympanic  remants  under  the  handle  of  malleus  and  mid-
dle  ear,  and  held  in  position  with  GelfoamTM fragments.
At  the  end  of  the  procedure,  the  incision  was  sutured  in
anatomical  planes,  and  a  pressure  dressing  was  applied.  The
patient  remained  in  the  hospital  until  the  next  day.  At  the
time  of  hospital  discharge,  cephalexin  500  mg,  orally,  four
times  daily  for  7  days  was  prescribed,  and  the  patient  was
instructed  to  return  to  his/her  activities  after  8--15  days.
For  patients  in  the  experimental  group,  the  procedure
was  performed  under  local  anesthesia  with  inﬁltration  of
xylocaine  (2%  solution)  5.0  ml  with  vasoconstrictor,  divided
into  two  parts:  2.5  ml  for  external  application  and  2.5  ml
into  the  external  auditory  canal.  The  perforation  edges
were  scariﬁed,  and  then  a  bacterial  cellulose  membrane
was  placed  over  the  perforation,  laterally  to  the  tympanic
remains.  The  membrane  was  held  in  place  by  self-adhesion.
The  patient  was  discharged  immediately  after  the  proce-
dure,  being  instructed  to  return  to  his/her  activities  without
restrictions.  Antibiotics  were  not  prescribed.
Outcomes  evaluated
Clinical  outcomes
In  both  groups,  the  following  variables  were  evaluated:  sur-
gical  time,  hospital  stay,  time  for  epithelialization,  TMP
closing  rate  in  t0 =  15  days,  t1 =  30  days  and  t2 =  60  days;  the
impedance  audiometry  curve  60  days  post-treatment,  and
adverse  events.
Hospital  costs  were  analyzed  separately  for  use  of
BC  (experimental  group)  versus  temporal  fascia  (control
group).  These  costs  were  estimated  according  to  the  table
of  the  Brazilian  Uniﬁed  Health  System  (SUS)  from  Min-
istry  of  Health,  2007,  taking  into  account:  for  autologous
fascia,  tympanoplasty  (uni/bilateral)  (code:  04.04.01.035-
0),  surgical  specialty  of  medium  complexity;  the  assigned
value  includes  one  (1)  day  of  hospitalization  (R$  388.94
per  patient);  for  BC  grafting,  a  grade  II  dressing  (code:
04.01.01.001-5),  surgical  specialty  of  medium  complexity,
with  no  inclusion  of  hospital  stay  (R$  30.00  per  patient).
Tympanometry:  The  evaluation  of  tympanic  membrane
mobility  was  obtained  based  on  the  impedance  chart,
considering  air  pressure  (marked  on  the  X  axis  in  decaPascal,
daPaX)  and  admittance  (on  the  Y  axis,  daPaY  in  ml).12
Effectiveness: Effectiveness  represents  the  rela-
tive  reduction  of  risk  or  of  negative  outcome  (TMP
closure)  obtained  with  the  intervention  (in  this  case,
the  use  of  BC).  Relative  risk  [RR  =  R(BC)/R  (fascia)]
was  calculated,  followed  by  absolute  reduction  in
risk  (ARR  =  [R(fascia)  −  R(BC)]  ×  100)  and  effectiveness
[EF  =  (1  −  RR)  ×  100]  calculations.  When  the  risk  is  equal
in  both  groups,  RR  =  1.  If  the  risk  for  intervention  group  is
lower  than  the  risk  for  control  group,  RR  <  1;  otherwise,
RR  >  1.
Parametric  continuous  variables  were  compared  using
Student’s  t  test,  while  scores  were  compared  using  thellulose  205
hi-squared  test.  Mann--Whitney  test  was  used  to  evaluate
he  sum  of  hospital  costs.  A  95%  conﬁdence  interval  was
sed,  and  the  statistical  signiﬁcance  was  set  at  p  ≤  0.05.
tatistical  analysis  was  performed  using  GraphPad  Prism  5.0
oftware  (GraphPad  Software  Inc.,  USA).
esults
 total  of  40  patients  underwent  treatment  for  tympanic
embrane  perforation;  20  received  a  BC  graft  (30%  men
nd  70%  women);  and  20  --  the  control  group  --  received
n  autologous  fascia  graft  (40%  men  and  60%  women).  The
ean  age  of  the  groups  was  38.15  ±  12.63,  and  34.5  ±  10.16
ears,  respectively  (Table  1).
In  the  group  of  patients  who  received  BC  graft,  65%  of
MPs  were  in  the  left  ear,  while  in  the  group  that  received
n  autologous  fascia  graft,  most  (55%)  TMPs  were  in  the  right
ar.  Perforations  were  more  often  of  small  size,  accounting
or  70%  of  cases  in  each  group.  Closure  occurred  in  all  small
erforations  treated  by  BC  graft,  when  compared  with  fas-
ia  graft  (92.9%).  More  than  half  (66.6%)  of  medium-sized
erforations  closed  with  BC  graft  (Table  1).
Surgical  time  for  the  procedure  was  statistically  signiﬁ-
ant  (p  <  0.001),  when  comparing  the  group  that  received
C  graft  (14.06  ±  5.23  min)  versus  autologous  fascia  graft
76.50  ±  17.92  min);  and  epithelialization  time  was  similar  in
oth  groups,  corresponding  to  30  days  (Table  1)  (Figs.  1--3).
To  evaluate  tympanic  membrane  compliance,  14  patients
reated  with  BC  graft  underwent  tympanometry,  and  of
hese,  13  (92.9%)  had  Gt  within  the  normal  range  (mean
t  =  0.86  ±  0.28)  and  an  expected  At  (−0.58  ±  0.28)  (Fig.  4).
The  relative  risk  (RR)  of  non-closure  of  tympanic  mem-Figure  1  Tympanic  perforation  on  otomicroscopy.
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Table  1  Outcomes  evaluated  between  groups  treated  with  bacterial  cellulose  and  autologous  fascia  grafts,  for  treatment  of
perforated tympanic  membrane.
Outcomes  Type  of  graft  p-Value
BC  Fascia
N  20  20  --
Gender
Male 06  (30%)  08  (40%)  0.5073a
Female  14  (70%)  12  (60%)
Age 38.15  ±  12.63  34.5  ±  10.16  0.3204b
TMP  location
Right  ear 7  (35.0%) 11(55.0%) 0.2036a
Left  ear  13  (65.0%)  9  (45.0%)
TMP size
Small  14  (70.0%)  14  (70.0%)  1.000a
Medium  6  (30.0%)  6  (30.0%)
Surgical time  (min)  14.06  ±  5.23  76.50  ±  17.92  <0.0001b*
TMP  closure
General  18  (90.0%)  16  (80.0%)  0.3758a
By  size
Small  14  (100%)  13  (92.9%)  0.6264a
Medium  04  (66.7%)  03  (50%)  0.5582a
Hospital  cost  estimatec
Per  patient 30.00 388.94
Total  600.00  7778.80  <0.0001c
Risk  and  efﬁcacy  analysis
RR%  0.5  0.3758a
ARR  10% --
Efﬁcacy  50%
BC, Bacterial cellulose; TMP, Tympanic membrane perforation; RR, Relative risk; ARR, Absolute risk reduction.
Values in mean ± SD and n (%).
a Qui-squared test.
b Student’s t test, signiﬁcant if (*) p ≤ 0.05.
c Hospital cost estimate, according to the table of costs for surgical p
Reais (R$). Mann--Whitney test.


















orocedures of the Brazilian Uniﬁed Health System (SUS); values in
BC  or  fascia),  despite  an  absolute  risk  reduction  of  10%  for
MP  closure  in  BC  group  (Table  1).
iscussion
onventionally  the  treatment  of  TMP  involves  three  steps:
re-operative  clinical  control,  surgical  treatment  and  post-
perative  follow-up.  The  main  objectives  of  miringoplasty,
n  general,  are  to  regenerate  the  tympanic  membrane,
econstruct  the  sound  transmission  mechanism,  control
nfection,  and  improve  hearing.  In  the  literature,  the  suc-
ess  rate  varies  from  65  to  98%.13,14 In  this  study,  our  success
ate  with  the  use  of  BC  membrane  was  90%,  compared  to  80%
ith  autologous  fascia.4 We  must  also  emphasize  that  the
se  of  BC  represented  an  efﬁciency  of  50%,  i.e.  the  chance
f  non-closure  of  tympanic  perforation  was  reduced  by  half
RR  =  0.5)  versus  temporal  fascia.  This  is  in  agreement  with
 previous  study,  which  followed  a  similar  methodology  and
as  conducted  in  Chinchilla  laniger,  where  the  authors
btained  a  90%  success  rate.11
Treatment  of  tympanic  membrane  perforation  using  bacterial  ce
Figure  3  Tympanic  membrane  after  application  of  bacterial






















































Sucesso (%) Risk of failure (%)
Figure  4  Relationship  between  material’s  sullulose  207
Some  factors  can  inﬂuence  the  success  of  the  surgery
r  of  the  graft,  as  follows:  age,  perforation  location,  size
f  perforation,  auditory  tube  function,  status  of  middle  ear
ucosa,  type  of  graft  used,  and  surgeon’s  experience.15 As
o  the  study  population,  it  can  be  added  that  the  use  of
C  membrane  was  effective,  regardless  of  patient’s  age  and
ocation  and  size  of  tympanic  perforation.  No  adverse  events
elated  to  this  membrane  occurred.  It  is  noteworthy  the
eduction  of  a  little  more  than  1  h  (62.44  min)  in  the  time
equired  for  the  procedure,  when  comparing  BC  group  versus
emporal  fascia  (control)  group,  indicating  that  BC,  in  addi-
ion  to  being  effective,  shows  a  high  level  of  effectiveness
nd  practicality.
The  reduction  in  the  operating  time  using  BC  membrane
s  self-explanatory,  because  there  was  no  need  for  incisions,
emoval  of  fascia,  or  lifting  ﬂaps.  From  the  cost  estimate  for
ach  procedure  (fascia  or  BC  membrane  graft),  we  found  a
eduction  of  13  times  in  hospital  costs  with  the  use  of  BC
embrane;  this  ﬁgure  represents  a  saving  of  R$  7,178.8,
onsidering  that,  with  the  choice  of  BC,  there  is  no  need  for
dditional  tests  (hematology  and  cardiology),  hospitaliza-
ion  or  general  anesthesia.  The  use  of  BC  also  obviates  the
se  of  special  materials,  such  as  GelfoamTM, suture  mate-
ial  and  antibiotics;  on  the  other  hand,  the  use  of  BC  avoids
omplications  such  as  ear  pain,  bleeding,  and  hematomas.
he  patient  can  resume  immediately  their  daily  activities.
To  these  aspects  we  can  add  efﬁciency,  effectiveness  and
racticality,  in  addition  to  security,  because  this  is  a  low-
ytotoxicity  and  high-biocompatibility  material.6,7
As  described  in  the  literature,  the  tympanic  membrane
hould  be  rebuilt  with  a  connective  tissue  that  allows  for,  in
eplacing  the  eardrum,  ensuring  its  properties:  elasticity,
trength  and  ability  to  vibrate.  Many  materials  have  been
sed  in  the  history  of  tympanoplasty,  including  free  skin
raft,  sclera,  perichondrium,  temporal  fascia,  cartilage,
nd  fat,  among  others.16,17 It  was  observed  that  these  prop-
rties  were  recovered,  with  proven  data  corroborated  by
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embrane  compliance  and  showed  that  most  patients
92.9%)  had  Gt  in  the  normal  range  and  At  as  expected.
ympanometry,  used  in  this  study  to  evaluate  tympanic
embrane  function,  is  a  classic  method  applied  in  clinical
ractice,  by  being  fast  and  atraumatic.18
Another  important  feature,  demonstrated  in  previ-
us  studies,  refers  to  BC’s  ability  to  function  as  an
nducer  of  tissue  remodeling  and,  thus,  as  a  promoter  of
he  healing  process,8--10 by  enabling  an  intensive  process
f  revascularization19 and  epithelialization,11 which  may
xplain  the  regeneration  of  the  eardrum  remains  and  also
he  closure  of  TMP.
onclusion
he  use  of  a  bacterial  cellulose  graft  promoted  TMP  regen-
ration,  showing  it  to  be  an  innovative,  safe,  efﬁcient,
ffective,  minimally  invasive,  low-cost  option.
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